Reanalysis Narrows Cerebral Palsy Gene List to 89 of 515, Framing Condition as Phenotypic Trait
The American Journal of Human Genetics study demonstrates that fewer than one-fifth of genes previously linked to cerebral palsy reach statistical significance. It proposes CP be treated as a clinical feature rather than a unitary disease. Larger prospective studies are needed before genetic panels alter diagnostic algorithms or care pathways.
If validated, the reframing could shift clinical practice toward earlier genomic testing and surveillance for non-motor complications. Prospective cohorts will be required to measure whether gene-specific management improves motor or cognitive outcomes compared with standard rehabilitation alone.
Robinson et al.: By 2028, at least two major pediatric neurology guidelines will require targeted gene panels covering the 89 validated genes for all new non-progressive motor impairment diagnoses.
Sources (2)
- [1]Primary Source(https://www.cell.com/ajhg/fulltext/S0002-9297(25)00312-4)
- [2]Supporting Source(https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(23)00234-5/fulltext)